Research Recalibrated
The spending race is over in pharmaceutical R&D, with companies now focused on doing more with less
Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Copyright © 2025 American Chemical Society
June 7, 2010 Cover
Volume 88, Issue 23
The spending race is over in pharmaceutical R&D, with companies now focused on doing more with less
Credit:
Business
Climate Debate Turns Foul
Scientists are being intimidated and harassed because of their research, they tell congress
Growing Chemicals
New biotech traits enable fuel and polymer production in crops
-
Enzyme’s Metal Cluster Is Nailed
Definitive solution of the structure of an enzyme in isoprenoid biosynthesis could lead to new antibiotics
-
Eastman Finds Its Stride
Executives have sworn off reinvention, instead focusing on what they think the company does best
-
Health Agencies Under Scrutiny
Congress, GAO point to consistent flaws in CDC units' environmental health practices
ADVERTISEMENT
Science Concentrates
Palladium-Mediated Insertive Behavior
Studies pin down key intermediates in versatile migratory alkene insertion reactions
